Advance Biofactures Corporation
1 clinical trials · Sponsor
◉ Watch Advance Biofactures Corporation
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids) (NCT02889848) | Advance Biofactures Corporation | 2016-10-27 |
Track Advance Biofactures Corporation automatically
Every clearance here is in the API, with alerts when new ones post.